Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.06 - $15.0 $111,793 - $128,400
-8,560 Reduced 68.35%
3,964 $58,000
Q4 2023

Feb 14, 2024

BUY
$12.02 - $13.41 $104,682 - $116,787
8,709 Added 228.28%
12,524 $167,000
Q2 2023

Aug 14, 2023

BUY
$12.02 - $13.07 $27,910 - $30,348
2,322 Added 155.53%
3,815 $46,000
Q1 2023

May 12, 2023

SELL
$11.35 - $12.32 $2,111 - $2,291
-186 Reduced 11.08%
1,493 $18,000
Q4 2022

Feb 10, 2023

BUY
$3.68 - $12.51 $526 - $1,788
143 Added 9.31%
1,679 $19,000
Q2 2022

Aug 12, 2022

BUY
$4.89 - $7.13 $1,467 - $2,139
300 Added 24.27%
1,536 $9,000
Q1 2022

May 16, 2022

SELL
$3.75 - $6.82 $78 - $143
-21 Reduced 1.67%
1,236 $8,000
Q4 2021

Feb 08, 2022

SELL
$3.75 - $5.1 $2,793 - $3,799
-745 Reduced 37.21%
1,257 $5,000
Q3 2021

Nov 15, 2021

BUY
$4.3 - $6.39 $2,799 - $4,159
651 Added 48.19%
2,002 $10,000
Q2 2021

Sep 13, 2021

BUY
$6.04 - $7.77 $8,160 - $10,497
1,351 New
1,351 $9,000

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.